Session » Systemic Sclerosis & Related Disorders – Clinical Poster II (1364–1390)
-
Abstract Number: 1364
Autologous Hematopoietic Stem Cell (HSC) Transplantation for Systemic Sclerosis, North American Registry: Updated Outcomes and the Impact of CD34+ HSC Enrichment
-
Abstract Number: 1365
Release of High-Mobility Group Box-1 After an Raynaud’s Attack Potentially Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production in Systemic Sclerosis
-
Abstract Number: 1366
The Use of Lipid-Lowering Agents in Systemic Sclerosis: Is There a Relationship with Prevalence of Digital Ulcers and Overall Survival?
-
Abstract Number: 1367
Associations of Esophageal Dysmotility Patterns with Extra-intestinal Features in Patients with Systemic Sclerosis
-
Abstract Number: 1368
Characterising Exercise Capacity in Systemic Sclerosis Using Cardiac Magnetic Resonance Imaging, Skeletal Muscle Imaging and Cardiopulmonary Exercise Testing
-
Abstract Number: 1369
Adipose Tissue-Derived Stromal Vascular Fraction Plus Fat Grafts for Hand Therapy in Patients with Systemic Sclerosis. a Randomized Controlled Clinical Trial
-
Abstract Number: 1370
Complement Factor D and Factor H Represent Disease and Severity Biomarkers for Systemic Sclerosis Associated Pulmonary Arterial Hypertension (SSc-PAH)
-
Abstract Number: 1371
Symptom Management in Systemic Sclerosis: A Pilot Study of a Web-based Intervention Using Peer-Health Coaches
-
Abstract Number: 1372
Outcomes and Risk Factors for Respiratory Failure in Patients with Scleroderma Associated with ILD
-
Abstract Number: 1373
Paraoxonase-1: Potential Novel Marker of Disease Extent and Activity in Systemic Sclerosis
-
Abstract Number: 1374
A Deep Neural Network Classifier to Identify Inflammatory Systemic Sclerosis Patients from Histological Images
-
Abstract Number: 1375
Improvement in Overall Survival, Skin Fibrosis and Lung Function with Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis
-
Abstract Number: 1376
Outcome Reporting in Systemic Sclerosis-Related Digital Ulcers: A Scoping Review
-
Abstract Number: 1377
Assessment of Autoantibodies and Clinical Associations in SSc Patients with ANA Positivity & Negative for Prototypic Autoantibodies
-
Abstract Number: 1378
Presence of Anti-RNA Polymerase 3 Antibody in Systemic Sclerosis, Renal Disease, Malignancy and ILD from a Single Academic Center Cohort
-
Abstract Number: 1379
Serum Levels of the Soluble Receptor for Advanced Glycation Endproducts Are Prospectively Associated with Pulmonary Arterial Hypertension in Systemic Sclerosis
-
Abstract Number: 1380
Quality of Life in Patients with Scleroderma Associated Calcinosis Cutis: A Cross-Sectional Study
-
Abstract Number: 1381
Chemokines CCL2 and CCL17 as Potential Serum Biomarkers for Interstitial Lung Disease in Systemic Sclerosis
-
Abstract Number: 1382
Survey on Treatment Practices in Subclinical Interstitial Lung Disease in Systemic Sclerosis
-
Abstract Number: 1384
A Genomic Meta-Analysis of Clinical Variables and Association with Intrinsic Molecular Subsets in Systemic Sclerosis
-
Abstract Number: 1385
Overall Survival in Patients with Systemic Autoimmune Diseases Following Lung or Heart-Lung Transplantation at a Single High-Volume Academic Transplant Center: A Comparative Cohort Study
-
Abstract Number: 1386
Measurement of TIMP-1 in Pulmonary Vessels May Be a Novel Marker of Reflecting mPAP in CTD-PH
-
Abstract Number: 1387
Macrovascular Dysfunction and Its Clinical Implication in Systemic Sclerosis
-
Abstract Number: 1388
Heterogeneity of Primary and Secondary Peristalsis in Systemic Sclerosis: A New Model of Scleroderma Esophagus
-
Abstract Number: 1389
Subclinical ILD Is Frequent and Progresses Across Different Connective Tissue Diseases